In order to clarify whether MDM2-induced Osimertinib resistance follows this dogma, we treated NSCLC cells with increasing concentrations of Osimertinib and determined the phosphorylation state of Akt and Erk. The gene discussed is MDM2; the disease is non-small cell lung carcinoma.